CSPIA
NNVC icon

Cary Street Partners Investment Advisory’s NanoViricides NNVC Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15
Closed -$20 – 1402
2023
Q3 		$20 Hold
15
– – ﹤0.01% 1859
2023
Q2 		$17 Hold
15
– – ﹤0.01% 1738
2023
Q1 		$18 Buy
+15
New +$20 ﹤0.01% 1667

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Cary Street Partners Investment Advisory's NNVC Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of NanoViricides (NNVC) in Q4 2023, closing a stake of 15 shares — an estimated $20 sold.

Cary Street Partners Investment Advisory first reported a position in NNVC in Q1 2023 and held it in 3 quarters. The position peaked at $20 in Q3 2023. 32 funds tracked by Wall St. Rank hold NNVC as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining NanoViricides position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 15 NanoViricides shares in Q4 2023, an estimated $20.
  • Cary Street Partners Investment Advisory first reported a position in NanoViricides in Q1 2023 and held it in 3 quarters.
  • Cary Street Partners Investment Advisory's NanoViricides position peaked at $20 in Q3 2023.
  • 32 funds tracked by Wall St. Rank held NanoViricides as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.